PMC:7100515 / 534-876 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T3","span":{"begin":6,"end":11},"obj":"Body_part"},{"id":"T4","span":{"begin":122,"end":129},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"hACE2 cells mainly through endocytosis, that PIKfyve, TPC2, and cathepsin L are critical for entry, and that SARS-CoV-2 S protein is less stable than SARS-CoV S. Polyclonal anti-SARS S1 antibodies T62 inhibit entry of SARS-CoV S but not SARS-CoV-2 S pseudovirions. Further studies using recovered SARS and COVID-19 patients’ sera show limited"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T9","span":{"begin":109,"end":117},"obj":"Disease"},{"id":"T10","span":{"begin":150,"end":158},"obj":"Disease"},{"id":"T11","span":{"begin":178,"end":182},"obj":"Disease"},{"id":"T12","span":{"begin":218,"end":226},"obj":"Disease"},{"id":"T13","span":{"begin":237,"end":245},"obj":"Disease"},{"id":"T14","span":{"begin":297,"end":301},"obj":"Disease"},{"id":"T15","span":{"begin":306,"end":314},"obj":"Disease"}],"attributes":[{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A13","pred":"mondo_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A14","pred":"mondo_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A15","pred":"mondo_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"hACE2 cells mainly through endocytosis, that PIKfyve, TPC2, and cathepsin L are critical for entry, and that SARS-CoV-2 S protein is less stable than SARS-CoV S. Polyclonal anti-SARS S1 antibodies T62 inhibit entry of SARS-CoV S but not SARS-CoV-2 S pseudovirions. Further studies using recovered SARS and COVID-19 patients’ sera show limited"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T10","span":{"begin":6,"end":11},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T11","span":{"begin":183,"end":185},"obj":"http://purl.obolibrary.org/obo/CLO_0050050"}],"text":"hACE2 cells mainly through endocytosis, that PIKfyve, TPC2, and cathepsin L are critical for entry, and that SARS-CoV-2 S protein is less stable than SARS-CoV S. Polyclonal anti-SARS S1 antibodies T62 inhibit entry of SARS-CoV S but not SARS-CoV-2 S pseudovirions. Further studies using recovered SARS and COVID-19 patients’ sera show limited"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T5","span":{"begin":122,"end":129},"obj":"Chemical"}],"attributes":[{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"hACE2 cells mainly through endocytosis, that PIKfyve, TPC2, and cathepsin L are critical for entry, and that SARS-CoV-2 S protein is less stable than SARS-CoV S. Polyclonal anti-SARS S1 antibodies T62 inhibit entry of SARS-CoV S but not SARS-CoV-2 S pseudovirions. Further studies using recovered SARS and COVID-19 patients’ sera show limited"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T1","span":{"begin":27,"end":38},"obj":"http://purl.obolibrary.org/obo/GO_0006897"}],"text":"hACE2 cells mainly through endocytosis, that PIKfyve, TPC2, and cathepsin L are critical for entry, and that SARS-CoV-2 S protein is less stable than SARS-CoV S. Polyclonal anti-SARS S1 antibodies T62 inhibit entry of SARS-CoV S but not SARS-CoV-2 S pseudovirions. Further studies using recovered SARS and COVID-19 patients’ sera show limited"}

{"project":"LitCovid-sentences","denotations":[{"id":"T6","span":{"begin":162,"end":264},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"hACE2 cells mainly through endocytosis, that PIKfyve, TPC2, and cathepsin L are critical for entry, and that SARS-CoV-2 S protein is less stable than SARS-CoV S. Polyclonal anti-SARS S1 antibodies T62 inhibit entry of SARS-CoV S but not SARS-CoV-2 S pseudovirions. Further studies using recovered SARS and COVID-19 patients’ sera show limited"}

{"project":"LitCovid-PubTator","denotations":[{"id":"31","span":{"begin":0,"end":5},"obj":"Gene"},{"id":"32","span":{"begin":54,"end":58},"obj":"Gene"},{"id":"33","span":{"begin":64,"end":75},"obj":"Gene"},{"id":"34","span":{"begin":248,"end":249},"obj":"Gene"},{"id":"35","span":{"begin":120,"end":121},"obj":"Gene"},{"id":"47","span":{"begin":109,"end":119},"obj":"Species"},{"id":"48","span":{"begin":218,"end":226},"obj":"Species"},{"id":"49","span":{"begin":237,"end":247},"obj":"Species"},{"id":"50","span":{"begin":315,"end":323},"obj":"Species"},{"id":"52","span":{"begin":150,"end":158},"obj":"Species"},{"id":"54","span":{"begin":306,"end":314},"obj":"Disease"}],"attributes":[{"id":"A31","pred":"tao:has_database_id","subj":"31","obj":"Gene:59272"},{"id":"A32","pred":"tao:has_database_id","subj":"32","obj":"Gene:219931"},{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"Gene:1514"},{"id":"A34","pred":"tao:has_database_id","subj":"34","obj":"Gene:43740568"},{"id":"A35","pred":"tao:has_database_id","subj":"35","obj":"Gene:43740568"},{"id":"A47","pred":"tao:has_database_id","subj":"47","obj":"Tax:2697049"},{"id":"A48","pred":"tao:has_database_id","subj":"48","obj":"Tax:694009"},{"id":"A49","pred":"tao:has_database_id","subj":"49","obj":"Tax:2697049"},{"id":"A50","pred":"tao:has_database_id","subj":"50","obj":"Tax:9606"},{"id":"A52","pred":"tao:has_database_id","subj":"52","obj":"Tax:694009"},{"id":"A54","pred":"tao:has_database_id","subj":"54","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"hACE2 cells mainly through endocytosis, that PIKfyve, TPC2, and cathepsin L are critical for entry, and that SARS-CoV-2 S protein is less stable than SARS-CoV S. Polyclonal anti-SARS S1 antibodies T62 inhibit entry of SARS-CoV S but not SARS-CoV-2 S pseudovirions. Further studies using recovered SARS and COVID-19 patients’ sera show limited"}